Past FSH Society fellows publish research paper “Correlation analysis of clinical parameters with epigenetic modifications in the DUX4 promoter in FSHD” in Epigenetics that proposes a prognostic marker that can… Read More »
Past FSH Society fellows publish research paper “Correlation analysis of clinical parameters with epigenetic modifications in the DUX4 promoter in FSHD”
Choice of transcriptional direction from each D4Z4 unit is an additional requirement for DUX4 production and having FSHD
FSHD research teams in Seattle, Rochester and Leiden add to the existing FSHD model loss of heterochromatin at D4Z4 and the presence of a specific haplotype on chromosome 4 are… Read More »
FSH Society grantees publish new paper “RNA Interference Inhibits DUX4-induced Muscle Toxicity In Vivo: Implications for a Targeted FSHD Therapy”
FSH Society grantees publish new paper “RNA Interference Inhibits DUX4-induced Muscle Toxicity In Vivo: Implications for a Targeted FSHD Therapy” in The American Society of Gene & Cell Therapy providing proof-of-principle… Read More »
Our latest publication from FSH Society’s Living with FSHD Series is now available!
Our latest publication from FSH Society’s Living with FSHD Series is now available! For details HERE. To read the “FSHD: A Guide for Schools” on-line PDF
FSH Watch Winter 2012
Highlights include: FSH Society Annual Donor Report FSH Society 2012 International Patient/Researcher Network Meeting Tentative Program Grant Awards for August 2011 New book Still Walking by Bill Moss. “These memoirs are the… Read More »